This report is the result of an extensive survey drawn from ICD
Research’s exclusive panel of leading pharmaceutical industry companies.
As numerous countries recover from the effects of the recession, this
report provides the reader with a definitive analysis of industry
outlook and explores how opportunities and demand are set to change in
2012–2013. Furthermore, the report not only grants access to the
opinions and strategies of business decision makers and competitors, but
also examines their actions concerning business priorities.
Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010–2012
The research source in this report is based on the surveyed opinions and forward-looking expectations of highly engaged and senior industry professionals. ICD Research conducted an extensive online survey during December 2011 and January 2012 taken by 247 senior global industry buyers and suppliers. These respondents cover C-levels, directors, managers and technical and professional staff.
Overall, throughout the global pharmaceutical industry, 47% of respondents are ‘more optimistic’ about revenue growth for their company over the next 12 months as compared with the previous 12 months. With the recovery of national economies in early 2010, revenue growth expectations increased in 2010 and rose further in 2011. However with the economic slowdown in the later part of 2011 in Europe and North America, companies were forced to rethink about their growth prospects for 2012. The top three key expected changes in business structure for 2012 include e the addition of ‘new products and service’ portfolios, ‘improvement of operational efficiency’, and ‘expansion in current markets’. Moreover, ‘new product development’ and ‘new facility acquisition’ will record significant increase in capital expenditure over the next 12 months.
Supplier Marketing Spend Activity, Marketing and Sales Behaviors and Strategies in the Pharmaceutical Industry - 2012–2013
Published: June 2012 No. of Pages: 75
Price: Single User License: US $ 1250 Corporate User License: US $ 3750
Reasons to buy
• Drive revenues by understanding future product investment areas and growth regions.
• Formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spend in the future.
• Better promote your business by aligning your capabilities and business practices with your customer’s changing needs.
• Secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
• Predict how the industry will grow, consolidate and where it will stagnate.
• Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.
Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010–2012
The research source in this report is based on the surveyed opinions and forward-looking expectations of highly engaged and senior industry professionals. ICD Research conducted an extensive online survey during December 2011 and January 2012 taken by 247 senior global industry buyers and suppliers. These respondents cover C-levels, directors, managers and technical and professional staff.
Overall, throughout the global pharmaceutical industry, 47% of respondents are ‘more optimistic’ about revenue growth for their company over the next 12 months as compared with the previous 12 months. With the recovery of national economies in early 2010, revenue growth expectations increased in 2010 and rose further in 2011. However with the economic slowdown in the later part of 2011 in Europe and North America, companies were forced to rethink about their growth prospects for 2012. The top three key expected changes in business structure for 2012 include e the addition of ‘new products and service’ portfolios, ‘improvement of operational efficiency’, and ‘expansion in current markets’. Moreover, ‘new product development’ and ‘new facility acquisition’ will record significant increase in capital expenditure over the next 12 months.
Supplier Marketing Spend Activity, Marketing and Sales Behaviors and Strategies in the Pharmaceutical Industry - 2012–2013
Published: June 2012 No. of Pages: 75
Price: Single User License: US $ 1250 Corporate User License: US $ 3750
Reasons to buy
• Drive revenues by understanding future product investment areas and growth regions.
• Formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spend in the future.
• Better promote your business by aligning your capabilities and business practices with your customer’s changing needs.
• Secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
• Predict how the industry will grow, consolidate and where it will stagnate.
• Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.
No comments:
Post a Comment